Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells

被引:72
作者
Terme, Magali [1 ]
Chaput, Nathalie [1 ,2 ]
Combadiere, Behazine [3 ]
Ma, Averil [5 ]
Ohteki, Toshiaki [6 ]
Zitvogel, Laurence [1 ,2 ,4 ]
机构
[1] Inst Gustave Roussy, INSERM, U805, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Invest Clin Biotherapie, F-94805 Villejuif, France
[3] Univ Paris 06, Lab Immunol Cellulaire, INSERM, U543,Hop Pitie Salpetriere, Paris, France
[4] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[6] Akita Univ, Dept Immunol, Grad Sch Med, Akita 010, Japan
关键词
D O I
10.4049/jimmunol.180.7.4679
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) play an important role in the control of peripheral tolerance by directly inhibiting conventional T cell proliferative and effector functions. However, the mechanisms by which Treg regulate the homeostasis of lymph nodes remain unclear. In this study, we show in a mouse model that Treg control two major checkpoints dictated by the interaction between self-reactive CD4(+) T cells and resident dendritic cell (DC) in secondary lympboid organs. First, Treg inhibit the production of CCR5 ligands, limiting the CCR5-dependent recruitment of DC in the lymph nodes. Second, Treg prevent the DC exposure of IL-15R alpha, markedly interfering in the DC-mediated NK cell proliferation in vivo. Therefore, the DC/T cell autoreactivity leading to NK cell triggering could potentially be controlled by the coinhibition of both IL-15R alpha and CCR5 in autoimmune disorders in which NK cells play a deleterious role.
引用
收藏
页码:4679 / 4686
页数:8
相关论文
共 70 条
[1]   DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction [J].
Adam, C ;
King, S ;
Allgeier, T ;
Braumüller, H ;
Lüking, C ;
Mysliwietz, J ;
Kriegeskorte, A ;
Busch, DH ;
Röcken, M ;
Mocikat, R .
BLOOD, 2005, 106 (01) :338-344
[2]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[3]   Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse [J].
Bates, Gaynor J. ;
Fox, Stephen B. ;
Han, Cheng ;
Leek, Russell D. ;
Garcia, Jose F. ;
Harris, Adrian L. ;
Banham, Alison H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5373-5380
[4]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[5]   Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in nonobese diabetic mice [J].
Carvalho-Pinto, C ;
García, MI ;
Gómez, L ;
Ballesteros, A ;
Zaballos, A ;
Flores, JM ;
Mellado, M ;
Rodríguez-Frade, JM ;
Balomenos, D ;
Martinez, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :548-557
[6]   The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis [J].
Chang, X ;
Gao, JX ;
Jiang, Q ;
Wen, J ;
Seifers, N ;
Su, LS ;
Godfrey, VL ;
Zuo, T ;
Zheng, P ;
Liu, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1141-1151
[7]   Exosomes as potent cell-free peptide-based vaccine.: II.: Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection [J].
Chaput, N ;
Schartz, NEC ;
André, F ;
Taïeb, J ;
Novault, S ;
Bonnaventure, P ;
Aubert, N ;
Bernard, J ;
Lemonnier, F ;
Merad, M ;
Adema, G ;
Adams, M ;
Ferrantini, M ;
Carpentier, AF ;
Escudier, B ;
Tursz, T ;
Angevin, E ;
Zitvogel, L .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2137-2146
[8]   Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi [J].
Chen, ML ;
Pittet, MJ ;
Gorelik, L ;
Flavell, RA ;
Weissleder, R ;
von Boehmer, H ;
Khazaie, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) :419-424
[9]   In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells [J].
Cooper, MA ;
Bush, JE ;
Fehniger, TA ;
VanDeusen, JB ;
Waite, RE ;
Liu, Y ;
Aguila, HL ;
Caligiuri, MA .
BLOOD, 2002, 100 (10) :3633-3638
[10]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949